Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice

Amylin is a peptide hormone cosecreted with insulin from the pancreatic beta-cells that can act as an osteoblast mitogen and as an inhibitor of bone resorption. The effects on bone of its systemic administration are uncertain.

Bibliographische Detailangaben

Veröffentlicht in:	American journal of physiology: endocrinology and metabolism 1998-10, Vol.38 (4), p.E694-E699
Hauptverfasser:	CORNISH, J, CALLON, K. E, KING, A. R, COOPER, G. J. S, REID, I. R
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Bones Bones, joints and connective tissue. Antiinflammatory agents Medical sciences Metabolism Pharmacology. Drug treatments Physical growth Rodents
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!